Background: The noninvasive diagnosis of chronic musculoskeletal infections remains a challenge. Recent studies have indicated that fluorine-18 fluorodeoxyglucose-positron emission tomography is a highly accurate imaging technique and is significantly more accurate than the combination of a bone scan and a white blood-cell scan for the diagnosis of chronic infection in the central skeleton (p < 0.05). However, patients who had had surgery within the previous two years were excluded from study. It was our aim to evaluate the technique in an unselected, clinically representative population. Methods: Sixty patients with a suspected chronic musculoskeletal infection involving the central skeleton (thirtythree patients) or the peripheral skeleton (twenty-seven patients) were studied with fluorine-18 fluorodeoxyglucosepositron emission tomography. Thirty-five patients had had surgery within the previous two years. The fluorine-18 fluorodeoxyglucose-positron emission tomography studies were read in a blinded, independent manner by two experienced readers. The final diagnosis was based on histopathological studies or microbiological culture (eighteen patients) or on clinical findings after at least six months of follow-up (forty-two patients). Results: On the final composite assessment, twenty-five patients had infection and thirty-five did not. All twentyfive infections were correctly identified by both readers. There were four false-positive findings; in two of these cases, surgery had been performed less than six months prior to the study. The sensitivity, specificity, and accuracy were 100%, 88%, and 93% for the whole group; 100%, 90%, and 94% for the subgroup of patients with a suspected infection of the central skeleton; and 100%, 86%, and 93% for the subgroup of patients with a suspected infection of the peripheral skeleton. Interobserver agreement was excellent (kappa = 0.97). Conclusions: Fluorine-18 fluorodeoxyglucose-positron emission tomography is highly accurate as a single technique for the evaluation of chronic musculoskeletal infections. It is especially valuable in the evaluation of the central skeleton, where white blood-cell scans are less useful. Because of its simplicity and high degree of accuracy, it has the potential to become a standard technique for the diagnosis of chronic musculoskeletal infections. Further studies are needed to assess its ability to identify infections at the sites of total joint replacements and to distinguish infection from aseptic loosening of these prostheses.
tion with white blood-cell scanning is generally accepted as a method with clinically good accuracy (range, 79% to 100%) for the diagnosis of infection involving the peripheral skeleton [12] [13] [14] [15] [16] [17] . The accuracy of this combined strategy is decreased (1) in the presence of low-grade chronic infections (lower sensitivity) 9, 12 ; (2) in the presence of periskeletal soft-tissue infection, because of the limited resolution of conventional nuclear imaging (lower sensitivity and specificity); (3) in the evaluation of the central skeleton, because of the presence of normal bone marrow and the possibility of so-called cold lesions (lower sensitivity and specificity) 12, 13, 15, [18] [19] [20] ; and (4) after trauma or surgery, because of the presence of ectopic hematopoietic bone marrow (lower specificity) 21, 22 . A combination of colloid scintigraphy and white blood-cell scanning has been associated with substantially improved specificity for the diagnosis of infection at the sites of hip and knee prostheses 19, 23, 24 , and a combination of bone and gallium scans has been proposed as a way to improve both sensitivity and specificity in the diagnosis of infection in the vertebral column 16 . However, the need for two techniques (a bone-marrow scan and a white blood-cell scan or a bone scan and a gallium scan) or even three techniques (a bone scan, a white blood-cell scan, and a bone-marrow scan) is not practical, adds to the cost and to the amount of radiation to which the patient is exposed, and is time-consuming. Therefore, an equally specific and sensitive all-in-one technique would be most welcome.
Fluorine-18 fluorodeoxyglucose-positron emission tomography has made it possible to evaluate cellular glucose metabolism [25] [26] [27] [28] . Specifically, this technique demonstrates the increased utilization of glucose by activated neutrophils and macrophages in inflammatory reactions [29] [30] [31] [32] . Sugawara et al. 33 showed, in a rat model, that the uptake of fluorine-18 fluorodeoxyglucose at the site of infection is higher than the uptake of other tracers and that the fluorine-18 fluorodeoxyglucoseuptake mechanism is related to the infiltration of inflammatory cells. Consequently, fluorine-18 fluorodeoxyglucose-positron emission tomography has been proposed as a promising technique for the evaluation of musculoskeletal infections 18, [33] [34] [35] [36] [37] [38] [39] . The purpose of the present study was to evaluate the accuracy of fluorine-18 fluorodeoxyglucose-positron emission tomography in the diagnosis of chronic musculoskeletal infections in an unselected series of sixty consecutive patients.
Materials and Methods

Patient Selection
Sixty patients (thirty-two females and twenty-eight males [mean age, 48.2 years; range, thirteen to seventy-five years]) in whom chronic osteomyelitis, spondylodiscitis, or an infection at the site of a total joint prosthesis was suspected were prospectively studied from February to August 1999. To avoid selection bias, fluorine-18 fluorodeoxyglucose-positron emission tomography was performed in conjunction with other clinically requested investigations and the scans were read in a blinded fashion. Suspected chronic osteomyelitis was defined as a possible recurrence of formerly proven osteomyelitis or as the presence of symptoms of osteomyelitis for more than six weeks 18, 34 . Fifty-two patients had a history of surgery at the site of the suspected infection. Patients who had had recent musculoskeletal surgery were not excluded (median interval between last surgery and scan, fourteen months; range, 1.5 to 269 months). Eight patients with no history of surgery had a soft-tissue infection with clinical suspicion of concomitant osteomyelitis (four patients) or a history of needle insertion into a vertebra (four patients). No patient had hematogenous chronic osteomyelitis. Thirtyfour patients had metallic implants in place at the time of scanning. Twenty-seven patients had a suspected infection of the peripheral skeleton, and thirty-three had a suspected infection of the central skeleton (the vertebrae, sacrum, coccyx, ribs, pelvis, proximal part of the femur, or proximal part of the humerus). Thirty-three patients were receiving antibiotics at the time of scanning.
Approval of the ethics committee was obtained, and the patients gave informed written consent prior to inclusion in the study. In eighteen patients the final diagnosis was based on the results of microbiological culture or histopathological examination, and in forty-two patients it was made after a clinical follow-up period of at least six months (median, nine months; range, six to twelve months). Clinical follow-up parameters 40 included (1) a decrease in pain and an improvement in local clinical inflammatory signs during antibiotic treatment, (2) improvement in laboratory inflammatory parameters, and (3) agreement among correlative imaging techniques (bone-scanning, white blood-cell scanning, magnetic resonance imaging, and, eventually, colloid scanning) (Tables I and II). The final diagnosis was made with use of all available clinical parameters by the referring orthopaedic surgeon, who was unaware of the results of fluorine-18 fluorodeoxyglucose-positron emission tomography.
Fluorine-18 Fluorodeoxyglucose-Positron Emission Tomography Imaging
All studies were performed with use of a positron emission tomography scanner (ECAT 951/31; Siemens/CTI, Knoxville, Tennessee) that provides thirty-one contiguous, 3.375-mmthick slices with an axial field of view of 108 mm. Patients fasted for at least six hours before administration of the fluorine-18 fluorodeoxyglucose. The blood-glucose level was checked in all patients by means of capillary sampling (Glucometer Elite; Diagnostics Division, Bayer, Tarrytown, New York) in order to exclude false-negative results due to elevated serum-glucose concentrations. The serum-glucose level prior to the injection of fluorine-18 fluorodeoxyglucose did not exceed 6.9 mmol/L in any patient, and no patient was given insulin to lower the serum-glucose level. Fluorine-18 fluorodeoxyglucose was injected at a dose of 370 MBq. Positron emission tomography scanning was started sixty minutes after injection. Depending on the area of interest (one to six bed positions), the total acquisition time ranged from fifteen to sixty minutes. Attenuation correction was not performed.
Image reconstruction was performed with the ordered- *THR = site of total hip replacement, and TSR = site of total shoulder replacement. †WBC = white blood-cell, MRI = magnetic resonance imaging, and CT = computerized tomography. ‡TP = true-positive finding, TN = true-negative finding, and FP = false-positive finding. #Bone and WBC scans were negative because of previous radiotherapy.
subsets expectation-maximization algorithm with two iterations and eight subsets.
Image Interpretation
Fluorine-18 fluorodeoxyglucose-positron emission tomography images were evaluated independently by two certified nuclear-medicine physicians experienced in positron emission tomography imaging; these physicians were blinded to the final diagnosis and to the results of other studies and laboratory results. In order for the two readers to become accustomed to *TKR = site of total knee replacement. †WBC = white blood-cell, and MRI = magnetic resonance imaging. ‡TN = true-negative finding, TP = true-positive finding, ind = indeterminate finding, and FP = false-positive finding.
the normal variations in skeletal uptake, normal skeletal variations were agreed upon after a review of the whole-body scans of thirty patients who had been referred for the evaluation of malignant melanoma. The results were graded on a three-point scale, with "-" indicating no increased uptake (no osteomyelitis), "0" indicating equivocal results (no clear spatial differentiation between increased uptake by soft tissue and bone could be made), and "+" indicating increased uptake inside the bone surface or adjacent to prosthetic material. Skeletal uptake was defined as being increased if it was higher than the muscle uptake at a comparable tissue depth and higher than the skeletal uptake on the contralateral side. When the contralateral side was not available for comparison, the uptake had to be deemed higher than that in healthy adjacent bone or marrow tissue. The uptake in what was judged to be the joint capsule was not considered positive for infection. The scores that were independently assigned by the two readers were compared with the final diagnosis. Sensitivity, specificity, and accuracy were calculated for each observer.
Statistical Analysis
Interobserver agreement concerning the absence or presence of osseous infection on the final composite assessment was determined with use of Cohen kappa statistics (a kappa value of 1.0 indicated perfect agreement; 0.81 to 0.99, very good agreement; 0.61 to 0.80, good agreement; 0.0 to 0.60, poor to moderate agreement; and 0.0, agreement that was no better than chance). Differences in proportion were assessed with use of a chi-square test.
Results he mean blood-glucose level of the sixty patients was 4.5 mmol/L (range, 3.4 to 6.9 mmol/L). Twenty-five patients (42%) were found to have osseous infection on the final composite assessment. Data on the individual patients are given in Tables I and II . Both readers correctly identified all infections on fluorine-18 fluorodeoxyglucose-positron emission tomography scans. When the "+" and "0" scores were classified as positive and the "-" scores were classified as negative, the sensitivity, specificity, and accuracy for the whole group were 100% (twenty-six of twenty-six), 88% (thirty of thirty-four), and 93% (fifty-six of sixty), respectively. The corresponding values for the subgroup of thirty-three patients who had a suspected infection of the central skeleton were 100% (thirteen of thirteen), 90% (eighteen of twenty), and 94% (thirty-one of thirty-three), and the values for the subgroup of twenty-seven patients who had a suspected infection of the peripheral skeleton were 100% (thirteen of thirteen), 86% (twelve of fourteen), and 93% (twenty-five of twenty-seven). The presence or absence of infection was accurately determined on the fluorine-18 fluorodeoxyglucose-positron emission tomography scans of all fifteen patients who had a suspected infection in the vertebral column (including the sacrum and the coccyx). Since the overall sensitivity was 100% in all populations, we concluded that sensitivity was not negatively influenced by antibiotic treatment or by the lack of attenuation correction. Seventeen patients were evaluated for a suspected periprosthetic infection involving the shoulder (three patients), hip (seven patients), or knee (seven patients). Scanning revealed eight true-positive results, eight true-negative results, and one false-positive result. The one false-positive result was recorded for a female patient (Case 51) who had intense uptake of fluorine-18 fluorodeoxyglucose at the total knee prosthesis-bone interface and in the joint capsule. Aseptic loosening and a hyperplastic capsule were noted at the time of surgery. All cultures remained negative.
In the group of patients without prostheses, there were three additional false-positive findings, with both readers assigning the same score. One patient (Case 10) had increased uptake at the interface between bone and the locking screw of an intramedullary nail; one patient (Case 7), who had been operated on six weeks earlier for the removal of a hip prosthesis, had increased uptake but was found to be free of infection at the time of reoperation one week after scanning; and a third patient (Case 60) had slightly increased uptake in the distal aspect of the femur four months after surgery.
Two of the four false-positive findings were in a small subgroup of ten patients who had had an operation at the site within six months before the positron emission tomography study. In contrast, there were only two false-positive findings among the remaining fifty patients. This difference, however, was not significant (p = 0.25).
Fifty-nine scans were interpreted similarly by both readers (kappa = 0.97). The remaining scan was interpreted differently by the two readers, who disagreed as to the location of (Fig. 3-A) and sagittal ( Fig. 3-B) fluorodeoxyglucose-positron emission tomography scans through the lumbar vertebrae of a thirteen-year-old girl in whom extreme scoliosis had been treated with osteosynthesis nine months earlier. She presented with lowback pain, an elevated erythrocyte sedimentation rate (109 mm at two hours), and an elevated level of C-reactive protein (3.18 mg/dL). The bone and white blood-cell scans were equivocal. The fluorodeoxyglucose-positron emission tomography scans show increased uptake (arrows) in the bodies of the third, fourth, and fifth lumbar vertebrae, where uptake is normally very low, as well as increased splenic uptake (arrowhead in Fig. 3-A) . Staphylococcus aureus grew on culture of specimens obtained at the time of the operation. 
Discussion
ecently, three studies were performed to evaluate the usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography for the diagnosis of musculoskeletal infections 18, 33, 36 . Sugawara et al. 33 reported on a small series of eleven patients who had a known or suspected infection. On the basis of the final clinical diagnosis, fluorine-18 fluorodeoxyglucosepositron emission tomography was found to have correctly identified the presence or absence of infection in ten of the eleven patients. In one patient, who had diabetes and an increased serum-glucose level, the infectious focus was missed because of suboptimal image quality.
Guhlmann et al. 18 reported on fifty-one patients in whom fluorodeoxyglucose-positron emission tomography and antigranulocyte antibody scintigraphy were used for the evaluation of suspected chronic osteomyelitis involving the peripheral skeleton (thirty-six patients) or the central skeleton (fifteen patients). Patients who had been operated on within the previous two years were excluded. The scans were evaluated in a blinded fashion by two readers. The two readers found that both techniques had an excellent degree of accuracy (97% and 95% for fluorodeoxyglucose-positron emission tomography and 86% and 92% for antigranulocyte antibody scintigraphy) when they were used to evaluate suspected lesions in the peripheral skeleton. However, the accuracy of fluorodeoxyglucose-positron emission tomography (93% and 100%) was found to be significantly higher (p < 0.05) than that of antigranulocyte antibody scintigraphy (73% and 80%) when the methods were used to evaluate suspected lesions in the central skeleton. In that prospective study, the presence or absence of infection was determined with surgical exploration in thirty-one patients and with clinical follow-up in twenty patients.
Kälicke et al. 36 reported on fifteen patients who had histologically confirmed chronic osteomyelitis (eight patients) or acute osteomyelitis (seven patients). Fluorodeoxyglucose-positron emission tomography yielded fifteen truepositive findings. However, the absence of negative findings in that series may raise questions concerning the selection criteria used.
In our early experience 41 , we found that fluorodeoxyglucose-positron emission tomography alone is more accurate than the combination of bone-scanning and white blood-cell scanning for the diagnosis of chronic musculoskeletal infections, especially those involving the central skeleton. In that study, two readers evaluated the scans of thirty-four patients who had a suspected infection involving the central skeleton (seventeen patients) or the peripheral skeleton (seventeen patients). The combination of bone-scanning and white bloodcell scanning was found to have an accuracy of 71% (reader 1) and 76% (reader 2) for the diagnosis of lesions in the central skeleton and an accuracy of 88% (both readers) for the diagnosis of lesions in the peripheral skeleton. The corresponding values for fluorodeoxyglucose-positron emission tomography were 94% (both readers) for lesions in the central skeleton and 94% (both readers) for those in the peripheral skeleton. The presence or absence of infection was determined with surgical exploration in nine patients and with clinical follow-up in twenty-five.
In concordance with the results reported by Guhlmann et al. 18 , the current study suggests that fluorodeoxyglucosepositron emission tomography is a highly accurate imaging technique for the evaluation of musculoskeletal infections. The advantages and disadvantages of fluorodeoxyglucosepositron emission tomography are summarized in Table III . Despite the absence of attenuation correction, the sensitivity in the present series was comparable with that reported by Guhlmann et al. However, the specificity in our series tended to be slightly lower. This finding was probably related to differences in patient selection: the prevalence of musculoskeletal infection in our series (twenty-five [42%] of sixty) was lower R 18 and the present study were performed to evaluate the usefulness of fluorodeoxyglucose-positron emission tomography in the diagnosis of chronic musculoskeletal infections. Except for the seven cases of acute osteomyelitis in the study by Kälicke et al. 36 , data on the usefulness of fluorodeoxyglucose-positron emission tomography in the detection of acute musculoskeletal infections have been limited to those from experimental animal models. Sugawara et al. 33 recently showed that, two to four days after Escherichia coli inoculation, fluorodeoxyglucose uptake was highly elevated in the calf muscle of rats. The uptake of fluorodeoxyglucose increased as soon as activated macrophages and leukocytes accumulated 33 . Larger series are needed to define the role of fluorodeoxyglucose-positron emission tomography in the evaluation of acute osteomyelitis. However, as accurate and less expensive techniques for the detection of acute osteomyelitis (such as magnetic resonance imaging and three-phase bone scintigraphy) are available, the added value of fluorodeoxyglucose-positron emission tomography is likely to be limited.
In concordance with the lower specificity that has been reported in association with the use of fluorodeoxyglucosepositron emission tomography for the evaluation of oncological patients in the early postoperative period 42 , it may be assumed that postoperative repair mechanisms can induce falsepositive fluorodeoxyglucose uptake. Repair mechanisms after surgery are characterized by granulation tissue, which may be responsible for increased fluorodeoxyglucose uptake 31 , thus mimicking infection on positron emission tomography scanning. Since two of the four false-positive findings in our study occurred in the small subgroup of ten patients who had had surgery within the previous six months, larger series of patients who have had a recent operation may be needed to define the appropriate timing of fluorodeoxyglucose-positron emission tomography scanning.
As both malignant and infectious lesions are fluorodeoxyglucose avid, differentiation between a tumor and an infection is not possible 18 . Therefore, we do not use this technique to distinguish between infection and malignancy.
Although there were no patients with pseudarthroses or recent fractures in our series, four patients (Cases 35, 48, 50, and 53) had sustained a fracture relatively recently (within the previous four to twelve months). None of the patients had false-positive uptake at the fracture site. Kälicke et al. 36 recently demonstrated that fluorodeoxyglucose uptake at the sites of fractures and pseudarthroses is significantly lower than it is at the sites of infections, thereby facilitating differentiation.
Seventeen patients (Cases 3, 4, 8, 11, 17, 20, 22, 24, 25, 31, 43, 44 , 51, 52, 55, 56, and 57) were evaluated for a suspected periprosthetic infection, and our preliminary results regarding the diagnosis of this type of infection are promising. There was, however, one false-positive finding in our study, in a patient with aseptic loosening of a total knee replacement. The cell-rich vascular areas of the interface tissue between implant and bone and the pseudocapsule around aseptically loose implants contain more activated macrophages and proliferating fibroblast-like cells than do the tissues around well-fixed implants [43] [44] [45] [46] [47] . This factor may explain the increased uptake of fluorodeoxyglucose in our patient. Therefore, it remains questionable whether fluorodeoxyglucose-positron emission tomography is able to differentiate between aseptic and septic loosening with a high degree of accuracy. Larger series of patients with surgically confirmed infections are needed before the routine clinical use of this method can be recommended for the evaluation of the especially difficult area around a loose total joint prosthesis.
False-negative findings due to elevated blood-glucose concentrations (particularly those higher than 11 mmol/L) are a well-known problem associated with fluorodeoxyglucosepositron emission tomography scanning for tumors. However, recent findings suggest that hyperglycemia does not influence fluorodeoxyglucose uptake (and therefore does not influence sensitivity) when this method is used to study infectious processes 48 . Until this relationship is clarified in larger series, we recommend stringent regulation of the serum-glucose concentration so that it does not exceed 11 mmol/L, as is the current practice in oncological fluorodeoxyglucose-positron emission tomography scanning. If necessary, rapid control of the blood-glucose level can be achieved with the subcutaneous administration of a glycemia-adjusted dose of rapid-acting insulin two hours prior to fluorodeoxyglucose injection.
Study Limitations
Although these results are promising and are in concordance with previously reported data 18, 34, 36, 38 , one must be aware that, because of ethical limitations (surgery was performed only when clinically indicated), histopathological and microbiological confirmation of the diagnosis was obtained for only eighteen of the sixty patients. In the other forty-two patients, the determination of whether an infection was indeed present was based on clinical findings after a minimum duration of follow-up of six months.
Thirty-three patients were receiving antibiotics at the time of the study, which might have negatively influenced the results of microbiological tests 2, 49 . The results concerning the diagnosis of infections around musculoskeletal prostheses are promising, but the presence of one false-positive finding in this limited subgroup of seventeen patients has to be stressed. Larger series are needed to assess the accuracy of fluorine-18 fluorodeoxyglucose-positron emission tomography in this subpopulation, in whom accurate assessment is particularly difficult.
In conclusion, fluorine-18 fluorodeoxyglucose-positron emission tomography is a highly accurate technique for the diagnosis of chronic musculoskeletal infections in routine clinical practice. It has the advantage of combining an extremely high negative predictive value with a very good specificity without the need for additional imaging. If this technique becomes more available through a wider distribu-tion of positron emission tomography and coincidence cameras and improved distribution of fluorodeoxyglucose, it has the potential to become a standard technique for the detection of musculoskeletal infections because it is simple and highly accurate. This is especially true with regard to chronic infections in the central skeleton, where fluorine-18 fluorodeoxyglucose-positron emission tomography can replace a combination of several other imaging techniques. Larger studies, however, are needed to assess its value for the diagnosis of infections in the first six months after surgery, for the detection of acute musculoskeletal infections, and especially for the evaluation of infections at the sites of total joint prostheses. No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this article. No funds were received in support of this study.
